Summary |
|
1 | (8) |
|
|
9 | (6) |
|
Understanding Synthetic Biology |
|
|
11 | (1) |
|
Assessing Potential Biodefense Concerns |
|
|
12 | (1) |
|
Mitigating Potential Biodefense Concerns |
|
|
12 | (1) |
|
|
13 | (2) |
|
2 Biotechnology In The Age Of Synthetic Biology |
|
|
15 | (8) |
|
What Is Synthetic Biology |
|
|
15 | (3) |
|
Implications of the Age of Synthetic Biology |
|
|
18 | (3) |
|
Specific Synthetic Biology Technologies and Applications |
|
|
21 | (2) |
|
3 Framework For Assessing Concern About Synthetic Biology Capabilities |
|
|
23 | (14) |
|
Approach to Developing the Framework |
|
|
23 | (2) |
|
Factors for Assessing Concern |
|
|
25 | (6) |
|
Applying the Framework in the Assessment of Concern |
|
|
31 | (6) |
|
4 Assessment Of Concerns Related To Pathogens |
|
|
37 | (22) |
|
Re-Creating Known Pathogens |
|
|
38 | (6) |
|
Making Existing Pathogens More Dangerous |
|
|
44 | (10) |
|
|
54 | (3) |
|
|
57 | (2) |
|
5 Assessment Of Concerns Related To Production Of Chemicals Or Biochemicals |
|
|
59 | (12) |
|
Manufacturing Chemicals or Biochemicals by Exploiting Natural Metabolic Pathways |
|
|
61 | (3) |
|
Manufacturing Chemicals or Biochemicals by Creating Novel Metabolic Pathways |
|
|
64 | (1) |
|
Making Biochemicals via In Situ Synthesis |
|
|
65 | (4) |
|
|
69 | (2) |
|
6 Assessment Of Concerns Related To Bioweapons That Alter The Human Host |
|
|
71 | (14) |
|
Modifying the Human Microbiome |
|
|
71 | (3) |
|
Modifying the Human Immune System |
|
|
74 | (3) |
|
Modifying the Human Genome |
|
|
77 | (4) |
|
|
81 | (4) |
|
7 Related Developments That May Impact The Ability To Effect An Attack Using A Synthetic Biology-Enabled Weapon |
|
|
85 | (10) |
|
Barriers to the Use of Bioweapons |
|
|
85 | (2) |
|
Relevant Convergent Technologies |
|
|
87 | (5) |
|
|
92 | (3) |
|
8 Options For Mitigating Concerns |
|
|
95 | (20) |
|
Current Mitigation Approaches and Infrastructure |
|
|
95 | (5) |
|
Mitigation Challenges Posed by Synthetic Biology |
|
|
100 | (4) |
|
Potential Opportunities to Advance Mitigation Capabilities |
|
|
104 | (8) |
|
|
112 | (3) |
|
9 Moving Forward: Conclusions And Recommendations |
|
|
115 | (14) |
|
Overarching Recommendation |
|
|
116 | (1) |
|
Concerns Posed by Synthetic Biology-Enabled Capabilities |
|
|
116 | (9) |
|
Future Use of the Framework |
|
|
125 | (1) |
|
Biodefense Implications of the Age of Synthetic Biology |
|
|
126 | (21) |
References |
|
129 | (18) |
Appendixes |
|
|
A Specific Synthetic Biology Concepts, Approaches, and Tools |
|
|
147 | (10) |
|
B Selected Prior Analyses Used to Inform the Framework |
|
|
157 | (6) |
|
C Questions to Stimulate Consideration of Framework Factors |
|
|
163 | (4) |
|
|
167 | (4) |
|
E Disclosure of Conflict of Interest |
|
|
171 | (2) |
|
|
173 | |